Federal agencies like FDA and CDC have cited the need for higher doses of naloxone to reverse opioid overdoses, especially as fentanyl and other synthetic opioids have crept into illegal drugs, causing overdose deaths to skyrocket.
Loren Bonner
This season, pharmacists should review the differences among COVID-19, influenza, the common cold, and seasonal allergies since many of the signs and symptoms are similar. Here’s what pharmacists need to know to guide patients in identifying and seeking relief for their illnesses.
Clarissa Chan, PharmD
Chronic pain is common in the U.S. population and one of the main reasons patients seek medical care. Between 10% to 60% of adults 18 years and older report experiencing chronic pain or persistent pain lasting at least three to six months, according to a November 2021 study by Michaud and colleagues published in the Journal of Personalized Medicine.
In December 2021, FDA permanently lifted a major restriction on medication abortions that had been temporarily lifted earlier in the COVID-19 pandemic. Prior to the pandemic, patients were required to pick up mifepristone in person from a certified prescriber.
Sonya Collins
In December 2021, FDA approved tezepelumab-ekko (Tezspire–Amgen Inc. and AstraZeneca), a first-in-class medication indicated for patients with severe asthma.
Johanna Taylor Katroscik, PharmD